Home > News > Arch raises $400 million venture fund
December 10th, 2007
Arch raises $400 million venture fund
Arch Venture Partners, the 21-year-old venture capital firm whose Seattle area investments include Allozyne, Trubion Pharmaceuticals and VLST, has raised a $400 million venture fund.
It is the firm's seventh fund. The money will be invested in early-stage companies in the biotechnology, advanced materials, nanotechnology and semiconductor sectors.
Silicon Catalyst Announces Partnership With imec to Support Semiconductor Start-Ups February 23rd, 2015
Ligar secures investment from Wallace Corporation to commercialise polymers that pick out good and bad molecules: Ground-breaking science innovation removes molecules in the wrong place from liquids February 15th, 2015
Harris & Harris Group Portfolio Company D-Wave Systems Raises an Additional $29 Million (CAD), Closing 2014 Financing at $62 Million (CAD) February 2nd, 2015
Ref signals deep impact as EPSRC announces £30 million for impact acceleration accounts (IAA) January 21st, 2015
Anousheh Ansari Wins the National Space Society's Space Pioneer Award for "Service to the Space Community" March 5th, 2015
Enhanced Graphene Components for Next Generation Racing Yacht March 5th, 2015
Get ready for NanoDays! March 5th, 2015
American Chemical Society Presidential Symposia: nanoscience, international chemistry March 5th, 2015